Karo Pharma AB
8
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections
Role: lead
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
Role: lead
Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis
Role: lead
Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.
Role: lead
Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms
Role: lead
Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts
Role: lead
Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis
Role: lead
Hemoclin Gel for the Treatment of Hemorrhoids
Role: lead
All 8 trials loaded